By Tamer Abdelhak, MD, FNCS
On Monday, Dec. 14, 2020, the Albany Medical Center neurocritical care team was one of the first Neuro ICU teams to receive the Pfizer COVID-19 vaccine. The team has been on the frontline of managing patients within Upstate New York who have suffered from catastrophic neurologic injuries, some with concomitant COVID-19 infection.
New York State was one of the most affected areas in the United States during the April 2020 surge of COVID pandemic. Albany Medical Center is a Level 1 trauma center and the Capital Region's only comprehensive stroke center, serving 3 million people in Upstate New York. The NeuroICU at Albany Medical Center is the region's only Neuro ICU, covering patients with catastrophic neurological injuries at a 15-bed capacity.
Tamer Abdelhak, MD, medical director of the Albany Medical Center Neuro ICU; Teresa Caringi, FNP; and Jacquie Sayers, PAC pose after receiving their first COVID-19 vaccine.
Tamer Abdelhak, MD, medical director of the Albany Medical Center Neuro ICU; Teresa Caringi, FNP; and Jacquie Sayers, PAC, pose with Dennis Mckenna, MD, CEO of Albany Medical Center.